Skip to main content
. 2021 Jul 19;12:686133. doi: 10.3389/fphar.2021.686133

FIGURE 4.

FIGURE 4

PLS-DA and OPLS-DA analysis on plasma samples in placebo group. (A) PLS-DA analysis in positive mode. (B) Permutation test of PLS-DA analysis in positive mode. (C) PLS-DA analysis in negative mode. (D) Permutation test of PLS-DA analysis in negative mode. (E) OPLS-DA analysis in positive mode. (F) Permutation test of OPLS-DA analysis in positive mode. (G) OPLS-DA analysis in negative mode. (H) Permutation test of OPLS-DA analysis in negative mode. Inline graphic: T1 (Placebo), Inline graphic: T2 (Placebo), Inline graphic: T3 (Placebo), Inline graphic: T4 (Placebo).